Insufficient scRNA-seq data for expression of IRS4 at single-cell level.
Insufficient scRNA-seq data for expression of IRS4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 98% | 116.77 | 641 / 653 | 17% | 1.81 | 101 / 605 |
ovary | 100% | 231.25 | 180 / 180 | 5% | 1.37 | 20 / 430 |
uterus | 94% | 117.78 | 159 / 170 | 3% | 1.95 | 16 / 459 |
brain | 49% | 40.70 | 1295 / 2642 | 2% | 0.12 | 16 / 705 |
skin | 32% | 6.80 | 576 / 1809 | 9% | 0.44 | 44 / 472 |
stomach | 35% | 7.19 | 126 / 359 | 3% | 0.73 | 10 / 286 |
prostate | 27% | 5.13 | 66 / 245 | 2% | 0.65 | 8 / 502 |
esophagus | 17% | 26.85 | 250 / 1445 | 10% | 0.59 | 18 / 183 |
lung | 15% | 3.36 | 85 / 578 | 10% | 1.83 | 121 / 1155 |
eye | 0% | 0 | 0 / 0 | 24% | 0.53 | 19 / 80 |
breast | 19% | 3.82 | 88 / 459 | 3% | 3.00 | 33 / 1118 |
bladder | 19% | 2.71 | 4 / 21 | 3% | 0.23 | 15 / 504 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.20 | 3 / 45 |
intestine | 3% | 0.48 | 32 / 966 | 1% | 0.31 | 6 / 527 |
pancreas | 3% | 0.46 | 11 / 328 | 0% | 0 | 0 / 178 |
blood vessel | 3% | 0.46 | 43 / 1335 | 0% | 0 | 0 / 0 |
adipose | 3% | 0.64 | 31 / 1204 | 0% | 0 | 0 / 0 |
spleen | 2% | 0.39 | 6 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 1.97 | 2 / 258 | 0% | 0.01 | 1 / 230 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.78 | 8 / 901 |
liver | 1% | 0.33 | 2 / 226 | 0% | 0 | 0 / 406 |
heart | 1% | 0.11 | 7 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.10 | 4 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.04 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005158 | Molecular function | insulin receptor binding |
GO_0043548 | Molecular function | phosphatidylinositol 3-kinase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | IRS4 |
Protein name | Insulin receptor substrate 4 Insulin receptor substrate 4 (IRS-4) (160 kDa phosphotyrosine protein) (py160) (Phosphoprotein of 160 kDa) (pp160) |
Synonyms | |
Description | FUNCTION: Acts as an interface between multiple growth factor receptors possessing tyrosine kinase activity, such as insulin receptor, IGF1R and FGFR1, and a complex network of intracellular signaling molecules containing SH2 domains. Involved in the IGF1R mitogenic signaling pathway. Promotes the AKT1 signaling pathway and BAD phosphorylation during insulin stimulation without activation of RPS6KB1 or the inhibition of apoptosis. Interaction with GRB2 enhances insulin-stimulated mitogen-activated protein kinase activity. May be involved in nonreceptor tyrosine kinase signaling in myoblasts. Plays a pivotal role in the proliferation/differentiation of hepatoblastoma cell through EPHB2 activation upon IGF1 stimulation. May play a role in the signal transduction in response to insulin and to a lesser extent in response to IL4 and GH on mitogenesis. Plays a role in growth, reproduction and glucose homeostasis. May act as negative regulators of the IGF1 signaling pathway by suppressing the function of IRS1 and IRS2. . |
Accessions | ENST00000372129.4 A0A804CF45 O14654 ENST00000564206.2 |